A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury

FASEB Journal

Volumn 27, Issue 11, 2013, Pages 4489-4499

  Campolo, Michela ^a   Esposito, Emanuela ^a   Ahmad, Akbar ^a   Di Paola, Rosanna ^a   Wallace, John L ^b   Cuzzocrea, Salvatore ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; Central nervous system; Inflammation; Motor recovery; Nonsteroidal anti inflammatory drug

Indexed keywords

3 NITROTYROSINE; ATB 346; CYCLOOXYGENASE 2; HYDROGEN SULFIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NAPROXEN; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CONTROLLED STUDY; DISEASE SEVERITY; GRANULOCYTE; MALE; MICROGLIA; MOTOR PERFORMANCE; MOUSE; MYELITIS; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SPINAL CORD INJURY; WHITE MATTER;

APOPTOSIS; CENTRAL NERVOUS SYSTEM; INFLAMMATION; MOTOR RECOVERY; NONSTEROIDAL ANTI-INFLAMMATORY DRUG;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; HYDROGEN SULFIDE; LOCOMOTION; MALE; MICE; NAPROXEN; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84887115583     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-234716     Document Type: Article

References (61)

1. Finnerup, N. B., and Johannesen., I. L., Sindrup, S. H., Bach, F. W., and Jensen, T. S. (2001) Pain and dysesthesia in patients with spinal cord injury: a postal survey. Spinal Cord 39, 256-262 (Pubitemid 32566072)
2. Siddall, P. J., and McClelland., J. M., Rutkowski, S. B., and Cousins, M. J. (2003) A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 103, 249-257 (Pubitemid 36638814)
3. Bareyre, F. M., and Schwab, M. E. (2003) Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays. Trends Neurosci. 26, 555-563 (Pubitemid 37176911)
4. DeWitt, D. S., and Prough., D. S., Taylor, C. L., and Whitley, J. M. (1992) Reduced cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and mild hemorrhage in cats. J. Neurosurg. 76, 812-821
5. Kruman, I. I., and Mattson, M. P. (1999) Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J. Neurochem. 72, 529-540 (Pubitemid 29055214)
6. Pedersen, M. O., Jensen, R., Pedersen, D. S., and Skjolding., A. D., Hempel, C, Maretty, L., and Penkowa, M. (2009) Metallothionein-I+II in neuroprotection. Biofactors 35, 315-325
7. Takahashi, H., Manaka, S., and Sano, K. (1981) Changes in extracellular potassium concentration in cortex and brain stem during the acute phase of experimental closed head injury. J. Neurosurg. 55, 708-717 (Pubitemid 12198481)
8. Yamakami, I., and McIntosh, T. K. (1989) Effects of traumatic brain injury on regional cerebral blood flow in rats as measured with radiolabeled microspheres. J. Cereb. Blood Flow Metab. 9, 117-124 (Pubitemid 19053443)
9. Zemper, E. D. (1994) Analysis of cerebral concussion frequency with the most commonly used models of football helmets. J. Athletic Training 29, 44-50
10. Yip, P. K., and Malaspina, A. (2012) Spinal cord trauma and the molecular point of no return. Mol. Neurodegen. 7, 6
11. Malaspina, A., Jokic, N., Huang, W. L., and Priestley,J. V. (2008) Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression. BMC Genom. 9, 500
12. Aimone, J. B., and Leasure., J. L., Perreau, V. M., and Thallmair, M. (2004) Spatial and temporal gene expression profiling of the contused rat spinal cord. Exp. Neurol. 189, 204-221 (Pubitemid 39221816)
13. Carmel, J. B., Galante, A., Soteropoulos, P., Tolias, P., Recce, M., Young, W., and Hart, R. P. (2001) Gene expression profiling of acute spinal cord injury reveals spreading inflammatory signals and neuron loss. Physiol. Genom. 7, 201-213 (Pubitemid 135707270)
14. Resnick, D. K., Schmitt, C, and Miranpuri., G. S., Dhodda, V. K., Isaacson, J., and Vemuganti, R. (2004) Molecular evidence of repair and plasticity following spinal cord injury. Neuroreport 15, 837-839 (Pubitemid 38453469)
15. Schmitt, C, and Miranpuri., G. S., Dhodda, V. K., Isaacson, J., Vemuganti, R., and Resnick, D. K. (2006) Changes in spinal cord injury-induced gene expression in rat are strain-dependent. Spine J. 6, 113-119
16. Lin, H., and Schlaepfer, W. W. (2006) Role of neurofilament aggregation in motor neuron disease. Ann. Neurol. 60, 399-406 (Pubitemid 44684975)
17. Mor-Vaknin, N., Punturieri, A., Sitwala, K., and Markovitz, D. M. (2003) Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5, 59-63 (Pubitemid 36054330)
18. Fiorucci, S., Antonelli, E., Distrutti, E., Rizzo, G., Mencarelli, A., Orlandi, S., Zanardo, R., Renga, B., Di Sante, M., Morelli, A., Cirino, G., and Wallace, J. L. (2005) Inhibition of hydrogen sulfide generation contributes to gastric injury caused by antiinflammatory nonsteroidal drugs. Gastroenterology 129, 1210-1224 (Pubitemid 41446861)
19. Wallace, J. L., Caliendo, G., Santagada, V., Cirino, G., and Fiorucci, S. (2007) Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology 132, 261-271 (Pubitemid 46108763)
20. Wallace, J. L., Dicay, M., McKnight, W., and Martin, G. R. (2007) Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 21, 4070-4076 (Pubitemid 350232363)
21. Zanardo, R. C., Brancaleone, V., Distrutti, E., Fiorucci, S., Cirino, G., and Wallace, J. L. (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 20, 2118-2120
22. Li, L., Bhatia, M., Zhu, Y. Z., and Zhu., Y. C., Ramnath, R. D., Wang, Z. J., and Anuar., F. B., Whiteman, M., Salto-Tellez, M., and Moore, P. K. (2005) Hydrogen sulfide is a novel mediator of lipopoly-saccharide-induced inflammation in the mouse. FASEB J. 19, 1196-1198 (Pubitemid 40946463)
23. Fiorucci, S., Orlandi, S., Mencarelli, A., Caliendo, G., Santagada, V., Distrutti, E., Santucci, L., Cirino, G., and Wallace, J. L. (2007) Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse mode of colitis. Br. J. Pharmacol. 150, 996-1002 (Pubitemid 46625099)
24. Wallace, J. L. (2007) Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol. Sci. 28, 501-505 (Pubitemid 47488507)
25. Abe, K., and Kimura, H. (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16, 1066-1071 (Pubitemid 26140863)
26. 2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun. 313, 362-368 (Pubitemid 37543594)
27. 2S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 20, 6008-6016 (Pubitemid 33049276)
28. Kimura, H. (2005) Hydrogen sulfide as a biological mediator. Antioxid. Redox Signal. 7, 778-780 (Pubitemid 40563218)
29. Kimura, H., Shibuya, N., and Kimura, Y. (2012) Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid. Redox Signal. 17, 45-57
30. Gong, Q. H., Wang, Q., Pan, L. L., and Liu., X. H., Huang, H., and Zhu, Y. Z. (2010) Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats. Pharmacol. Biochem. Behav. 96, 52-58
31. Chu, Q. J., He, L., Zhang, W., Liu, C. L., and Ai., Y. Q., and Zhang, Q. (2013) Hydrogen sulfide attenuates surgical trauma-induced inflammatory response and cognitive deficits in mice. J. Surg. Res. 183, 330-336
32. Tan, B. H., and Wong., P. T., and Bian, J. S. (2010) Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochem. Int. 56, 3-10
33. Wallace, J. L., Caliendo, G., Santagada, V., and Cirino, G. (2010) Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br. J. Pharmacol. 159, 1236-1246
34. Kearney, P. M., Baigent, C., Godwin, J., Halls, H., and Emberson., J. R., and Patrono, C. (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? - meta-analysis of randomised trials. BMJ 332, 1302-1308
35. Genovese, T., Esposito, E., Mazzon, E., Di Paola, R., Muia, C., Meli, R., Bramanti, P., and Cuzzocrea, S. (2008) Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. Shock 30, 142-152
36. Scott, G. S., Cuzzocrea, S., Genovese, T., and Hooper, D. C. (2005) Uric acid protects against secondary damage after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 102, 3483-3488 (Pubitemid 40328071)
37. Blackler, R., Syer, S., Bolla, M., Ongini, E., and Wallace, J. L. (2012) Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence. PLoS One 7, e35196
38. Basso, D. M., and Fisher., L. C., Anderson, A. J., Jakeman, L. B., and McTigue., D. M., and Popovich, P. G. (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635-659 (Pubitemid 43728052)
39. Boughton-Smith, N. K., Wallace, J. L., and Whittle, B. J. R. (1988) Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25, 115-123
40. Bethea, J. R., Castro, M., Keane, R. W., and Lee., T. T., Dietrich, W. D., and Yezierski, R. P. (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18, 3251-3260 (Pubitemid 28186018)
41. Vane, J. R., and Mitchell., J. A., Appleton, I., Tomlinson, A., Bishop-Bailey, D., Croxtall, J., and Willoughby, D. A. (1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U. S. A. 91, 2046-2050 (Pubitemid 24092039)
42. Kwon, B. K., Tetzlaff, W., Grauer, J. N., Beiner, J., and Vaccaro, A. R. (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4, 451-464 (Pubitemid 38992289)
43. Bracken, M. B. (1990) Methylprednisolone in the management of acute spinal cord injuries. Med. J. Aust. 153, 368 (Pubitemid 20297099)
44. Chvatal, S. A., and Kim., Y. T., Bratt-Leal, A. M., Lee, H., and Bellamkonda, R. V. (2008) Spatial distribution and acute anti-inflammatory effects of methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials 29, 1967-1975
45. Kimura, Y., and Kimura, H. (2004) Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 18, 1165-1167 (Pubitemid 39561558)
46. Goubern, M., Andriamihaja, M., Nubel, T., Blachier, F., and Bouillaud, F. (2007) Sulfide, the first inorganic substrate for human cells. FASEB J. 21, 1699-1706 (Pubitemid 46855615)
47. Kimura, Y., Goto, Y., and Kimura, H. (2010) Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid. Redox Signal. 12, 1-13
48. Elrod, J. W., and Calvert., J. W., Morrison, J., Doeller, J. E., and Kraus., D. W., Tao, L., Jiao, X., Scalia, R., Kiss, L., Szabo, C., Kimura, H., Chow, C. W., and Lefer, D. J. (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. U. S. A. 104, 15560-15565 (Pubitemid 47502956)
49. Li, L., Salto-Tellez, M., Tan, C. H., Whiteman, M., and Moore, P. K. (2009) GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic. Biol. Med. 47, 103-113
50. Blight, A. R. (1992) Macrophages and inflammatory damage in spinal cord injury. J. Neurotrauma 9(Suppl. 1), S83-S91
51. Gomes-Leal, W., Corkill, D. J., and Picanco-Diniz, C. W. (2005) Systematic analysis of axonal damage and inflammatory response in different white matter tracts of acutely injured rat spinal cord. Brain Res. 1066, 57-70 (Pubitemid 41790729)
52. La Rosa, G., Cardali, S., Genovese, T., Conti, A., Di Paola, R., La Torre, D., Cacciola, F., and Cuzzocrea, S. (2004) Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. J. Neurosurg. 1, 311-321
53. Verma, I. M. (2004) Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann. Rheum. Dis. 63(Suppl 2), ii57-ii61 (Pubitemid 39424659)
54. Matsuyama, Y., Sato, K., Kamiya, M., Yano, J., Iwata, H., and Isobe, K. (1998) Nitric oxide: a possible etiologic factor in spinal cord cavitation. J. Spinal Disorders 11, 248-252 (Pubitemid 28278173)
55. Liu, K. L., and Chen., H. W., Wang, R. Y., Lei, Y. P., and Sheen., L. Y., and Lii, C. K. (2006) DATS reduces LPS-induced iNOS expression, NO production, oxidative stress, and NF-kappaB activation in RAW 264.7 macrophages. J. Agric. Food Chem. 54, 3472-3478
56. Genovese, T., Mazzon, E., Mariotto, S., Menegazzi, M., Cardali, S., Conti, A., Suzuki, H., Bramanti, P., and Cuzzocrea, S. (2006) Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J. Neurosurg. 4, 145-153 (Pubitemid 47325304)
57. Bao, F., and Liu, D. (2003) Peroxynitrite generated in the rat spinal cord induces apoptotic cell death and activates caspase-3. Neuroscience 116, 59-70 (Pubitemid 36110432)
58. Whiteman, M., and Armstrong., J. S., Chu, S. H., Jian-Ling, S., Wong, B. S., and Cheung., N. S., Halliwell, B., and Moore, P. K. (2004) The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J. Neurochem. 90, 765-768 (Pubitemid 38989409)
59. Mattson, M. P. (2000) Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129
60. Emery, E., Aldana, P., Bunge, M. B., Puckett, W., Srinivasan, A., Keane, R. W., Bethea, J., and Levi, A. D. (1998) Apoptosis after traumatic human spinal cord injury. J. Neurosurg. 89, 911-920 (Pubitemid 28544043)
61. Wallace JL, Cirino G, Santagada V., and Caliendo, G. (2008). Hydrogen sulfide derivatives of nonsteroidal anti-inflammatory drugs. U.S. Patent Application No. WO/2008/009127